Purdue Pharmaceuticals L.P.
United States
61 articles about Purdue Pharmaceuticals L.P.
-
Shionogi And Purdue Pharma L.P. Establish Alliance For Joint U.S. Commercialization Of Naldemedine
12/19/2016
-
Purdue Pharma L.P. Inks $790 Million Pain Deal With Gates-Backed Exicure
12/12/2016
-
Purdue Pharma L.P. And Anabios Collaborate To Advance Research For Non-Opioid, Non-NSAID Treatments For Chronic Pain
12/5/2016
-
UTHealth, Purdue Pharma L.P. Enter Long-Term Research & Education Alliance
11/16/2016
-
Purdue Pharma L.P. Thwarted Plan To Limit OxyContin Prescriptions At Dawn Of Opioid Epidemic
10/26/2016
-
Purdue Pharma L.P. Release: Observational Study Finds Errors In Online Opioid Drug Information, Potentially Risking Patient Safety
10/17/2016
-
Company Profile For Purdue Pharma L.P.
9/2/2016
-
Purdue Pharma L.P. To Present Data From Research Studies At PainWeek 2016 Annual Conference
9/1/2016
-
University of Nebraska Medical Center, Purdue Pharma L.P. Enter Partnership To Advance New Drug Development
8/31/2016
-
Purdue Pharma L.P. Joins The National Pharmaceutical Council
8/4/2016
-
Egalet Settles Patent Litigations With Purdue Pharma L.P.
5/23/2016
-
Mundipharma And Purdue Pharma L.P. Reach A New Deal To In-Licence From ESTEVE Full Global Rights And Development Responsibilities For Novel First-In-Class Sigma-1 Antagonist (S1A Or MR309/E-52862)
5/16/2016
-
Mundipharma And Purdue Pharma L.P. Expand Pain Pipeline With New Deal For First-In-Class Sigma-1 Antagonist (S1A Or MR309/E-52862) From ESTEVE
5/16/2016
-
Purdue Pharma L.P. Announces The Appointment Of Alan W. Dunton, M.D. To Senior Vice President Of Research & Development
11/19/2015
-
FDA Panel Votes 23 to 1 Against Purdue Pharma L.P.’s New OxyContin Formulation
9/14/2015
-
Purdue Pharma L.P. Buys TrkA Program from VM Pharma LLC in $213 Million Deal
9/8/2015
-
Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President Of Medical Affairs
11/17/2014
-
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII
10/9/2014
-
Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources
9/15/2014
-
FDA To Expedite Review Of Purdue Pharma L.P. Once-Daily Painkiller Tablet
7/8/2014